A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors
Clinical trial NCT05518045 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05518045
- Sponsor
- LaNova Medicines Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-26
- Primary completion
- 2026-03-31
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.